Macquarie Group Ltd. raised its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,079,066 shares of the medical instruments supplier’s stock after acquiring an additional 57,510 shares during the quarter. Macquarie Group Ltd. owned approximately 1.97% of Merit Medical Systems worth $55,248,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the company. BlackRock Inc. boosted its stake in shares of Merit Medical Systems by 11.0% during the 2nd quarter. BlackRock Inc. now owns 7,045,772 shares of the medical instruments supplier’s stock worth $360,744,000 after acquiring an additional 698,458 shares during the last quarter. Eagle Asset Management Inc. lifted its stake in shares of Merit Medical Systems by 8.0% during the 2nd quarter. Eagle Asset Management Inc. now owns 2,026,120 shares of the medical instruments supplier’s stock valued at $103,737,000 after buying an additional 150,902 shares in the last quarter. Carillon Tower Advisers Inc. lifted its stake in shares of Merit Medical Systems by 22.2% during the 2nd quarter. Carillon Tower Advisers Inc. now owns 1,068,907 shares of the medical instruments supplier’s stock valued at $54,728,000 after buying an additional 194,196 shares in the last quarter. Voya Investment Management LLC lifted its stake in shares of Merit Medical Systems by 4.4% during the 2nd quarter. Voya Investment Management LLC now owns 1,032,103 shares of the medical instruments supplier’s stock valued at $52,844,000 after buying an additional 43,921 shares in the last quarter. Finally, Frontier Capital Management Co. LLC lifted its stake in shares of Merit Medical Systems by 74.8% during the 2nd quarter. Frontier Capital Management Co. LLC now owns 916,409 shares of the medical instruments supplier’s stock valued at $46,920,000 after buying an additional 392,203 shares in the last quarter. Institutional investors and hedge funds own 86.97% of the company’s stock.

A number of research analysts recently weighed in on the stock. Zacks Investment Research upgraded shares of Merit Medical Systems from a “sell” rating to a “hold” rating in a research note on Thursday, July 26th. Barrington Research lifted their target price on shares of Merit Medical Systems from $50.00 to $61.00 and gave the company an “outperform” rating in a research note on Tuesday, July 24th. Bank of America cut shares of Merit Medical Systems from a “buy” rating to an “underperform” rating and set a $64.00 target price on the stock. in a research note on Tuesday, August 7th. Needham & Company LLC lifted their target price on shares of Merit Medical Systems from $54.00 to $67.00 and gave the company a “buy” rating in a research note on Tuesday, July 24th. Finally, SunTrust Banks lifted their target price on shares of Merit Medical Systems to $68.00 and gave the company a “buy” rating in a research note on Monday, August 27th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $63.25.

Shares of NASDAQ MMSI opened at $62.05 on Friday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.66. The firm has a market capitalization of $3.35 billion, a price-to-earnings ratio of 48.48, a P/E/G ratio of 2.89 and a beta of 1.33. Merit Medical Systems, Inc. has a 52-week low of $36.21 and a 52-week high of $62.70.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Monday, July 23rd. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. The company had revenue of $224.81 million for the quarter, compared to the consensus estimate of $214.64 million. Merit Medical Systems had a net margin of 2.44% and a return on equity of 10.48%. Merit Medical Systems’s revenue for the quarter was up 20.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.36 EPS. equities analysts forecast that Merit Medical Systems, Inc. will post 1.64 earnings per share for the current year.

In other news, Director Franklin J. Miller sold 7,206 shares of the business’s stock in a transaction dated Monday, June 25th. The shares were sold at an average price of $50.60, for a total value of $364,623.60. Following the sale, the director now directly owns 12,744 shares in the company, valued at approximately $644,846.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Franklin J. Miller sold 1,500 shares of the business’s stock in a transaction dated Thursday, June 21st. The stock was sold at an average price of $50.05, for a total transaction of $75,075.00. Following the completion of the sale, the director now owns 12,744 shares in the company, valued at $637,837.20. The disclosure for this sale can be found here. Insiders own 5.00% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management.

Read More: How to Calculate Compound Annual Growth Rate (CAGR)

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.